KPMG has been announced as the sponsor of a session on data literacy at Digital Health’s AI and Data 2023 event, which will take place at London’s Business Design Centre on 30-31 October. The global…
Continue Reading
Qure.ai, a prominent medical AI firm, has received FDA clearance for its qXR chest X-ray solution, enabling the triage of pneumothorax and pleural effusion. Qure.ai’s qXR algorithm demonstrated exceptional accuracy and rapid notification capabilities….
Continue Reading
Barking, Havering and Redbridge University Hospitals NHS Trust is to move away from paper-based records, after selecting a new electronic patient record (EPR) from Oracle Cerner.The 10-year deal is worth £44 million, with HSJ…
Continue Reading
Digital Health AI and Data 2023 has welcomed Nuance Healthcare as a major sponsor of the upcoming event, which runs 30-31 October at London’s Business Design Centre. The new conference is for everyone working…
Continue Reading
London-based multinational digital health firm Babylon has sold almost all of its UK assets to digital health company eMed Healthcare UK, a subsidiary of US company eMed, after announcing in early August that its deal to…
Continue Reading
Former NHS England chief operating officer Sir David Sloman has joined leading virtual ward technology provider Doccla as a senior advisor.Sloman was previously appointed as NHSE’s chief operating officer in December 2021. Before that…
Continue Reading
Dr Hatim Abdulhussein, the national clinical lead for AI and Digital Workforce at NHS England, and Dr Nadine Hachach-Haram, founder and CEO of Proximie have been confirmed as speakers for Digital Health AI and Data 2023. The Digital…
Continue Reading
AI-driven technology detects Parkinson’s disease up to seven years before symptoms appear by analyzing eye scans. Moorfields Eye Hospital and University College London researchers utilized AI to identify markers within retinal images, aiding early…
Continue Reading
Researchers at Moorfields Eye Hospital and the University College London have used artificial intelligence technology to pinpoint markers within eye scans and identify the existence of Parkinson’s disease an average of seven years before…
Continue Reading
MRI scans combined with PSA density in prostate cancer screening, pioneered by a UCL-led study, identified cases missed by PSA tests alone. The REIMAGINE study revealed that 15 participants with significant cancer had ‘low’…
Continue Reading
